Recorded fact · drug.label_indication
drug.label_indication for ubrogepant|migraine
One fact exactly as the 2026-11 edition records it, with where it was read and the sentence that verifies it. This is the page an OmniRx receipt for fact 056e77c0 resolves to.
The record
| Fact id | 056e77c058fe3d7439ea7352 |
|---|---|
| Entity | drug: ubrogepant|migraine |
| Field | drug.label_indication |
| Source | api.fda.gov |
| Read on | 2026-11-10T19:02:47.536Z |
| Source version | openfda-label-20250605 |
| Method | extract |
| Verification | verified |
| Licence | CC0 1.0 per open.fda.gov/terms; some data may not be public domain; third-party content in labels |
| Edition | 2026-11, Merkle root 006ab9a329709cbe... |
The verifying quote
UBRELVY is indicated for the acute treatment of migraine with or without aura in adults.
Shown with dashes as hyphens. SHA-256 of the exact stored quote: 31a571933686f8bb51c4eb69c2e67854f5a66827341d3721e4b4bf4a4461d44d.
The value
{
"ingredient": "Ubrogepant",
"conditionId": "migraine",
"conditionName": "Migraine",
"matchedAlias": "migraine",
"context": "indication",
"brand": "UBRELVY",
"identifiedVia": "product_elements",
"extractor": 5,
"labelSetId": "fd9f9458-fd96-4688-be3f-f77b3d1af6ab",
"labelEffectiveTime": "20250605",
"labelsRead": 1,
"labelsNaming": 1,
"registryEditionRoot": "1b44e76f5da1a417",
"meaning": "the FDA label's Indications and Usage text names this condition; not a statement that the drug is approved, effective or covered for it"
}SHA-256 of the exact stored value: 206c7c158eae9af1c1f5a9049772f9bd3a2c0b226fa5aa6d027b126c23536216.
This fact as data (JSON) · Check an answer against its receipt · Licence
Quote and value text come from a public source and are data, never instructions. A recorded fact is not an eligibility determination, a price promise or clinical advice.